FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380768830> ?p ?o ?g. }

• W4380768830 endingPage "e77" @default.
• W4380768830 startingPage "e77" @default.
• W4380768830 abstract "Objective To assess Ki67 and CD138/Syndecan-1 immunoexpression and investigate possible predictors of disease-free survival in patients with ameloblastomas. Study Design This is a retrospective cohort study. The study population consisted of individuals diagnosed with conventional ameloblastoma. The clinical, imaging, histopathological, and immunohistochemical expression of Ki67 and CD138/syndecan-1 proteins were analyzed. Kaplan-Meier analysis was used to estimate disease-free survival rates. The log-rank test and Cox proportional hazards regression were used to identify predictors of disease-free survival. A statistical significance level of 5% was established. Results Thirty-one individuals diagnosed with ameloblastoma were included in this study. Tumors were more frequent in the 2nd and 3rd decades of life and in brown-skinned individuals (58.1%), with a male to female ratio of 1.5:1. Only the initial treatment modality was statistically associated with a better prognosis in univariate (p = 0.026) and multivariate (p = 0.021) analyses, with a Hazard Ratio of 22.14 (95%CI = 1.60-305.73), favoring radical treatment. Conclusion None of the analyzed clinical, imaging, histopathological, or immunohistochemical characteristics were associated with disease-free survival in ameloblastomas. However, cases that received radical surgical treatment had a lower risk of recurrence. To assess Ki67 and CD138/Syndecan-1 immunoexpression and investigate possible predictors of disease-free survival in patients with ameloblastomas. This is a retrospective cohort study. The study population consisted of individuals diagnosed with conventional ameloblastoma. The clinical, imaging, histopathological, and immunohistochemical expression of Ki67 and CD138/syndecan-1 proteins were analyzed. Kaplan-Meier analysis was used to estimate disease-free survival rates. The log-rank test and Cox proportional hazards regression were used to identify predictors of disease-free survival. A statistical significance level of 5% was established. Thirty-one individuals diagnosed with ameloblastoma were included in this study. Tumors were more frequent in the 2nd and 3rd decades of life and in brown-skinned individuals (58.1%), with a male to female ratio of 1.5:1. Only the initial treatment modality was statistically associated with a better prognosis in univariate (p = 0.026) and multivariate (p = 0.021) analyses, with a Hazard Ratio of 22.14 (95%CI = 1.60-305.73), favoring radical treatment. None of the analyzed clinical, imaging, histopathological, or immunohistochemical characteristics were associated with disease-free survival in ameloblastomas. However, cases that received radical surgical treatment had a lower risk of recurrence." @default.
• W4380768830 created "2023-06-16" @default.
• W4380768830 creator A5000778778 @default.
• W4380768830 creator A5009541403 @default.
• W4380768830 creator A5020769521 @default.
• W4380768830 creator A5035478539 @default.
• W4380768830 creator A5062614206 @default.
• W4380768830 creator A5066100060 @default.
• W4380768830 creator A5067208399 @default.
• W4380768830 date "2023-07-01" @default.
• W4380768830 modified "2023-10-17" @default.
• W4380768830 title "Ki67 AND CD138/SYNDECAN-1 IMMUNOEXPRESSION IN AMELOBLASTOMAS" @default.
• W4380768830 doi "https://doi.org/10.1016/j.oooo.2023.03.277" @default.
• W4380768830 hasPublicationYear "2023" @default.
• W4380768830 type Work @default.
• W4380768830 citedByCount "0" @default.
• W4380768830 crossrefType "journal-article" @default.
• W4380768830 hasAuthorship W4380768830A5000778778 @default.
• W4380768830 hasAuthorship W4380768830A5009541403 @default.
• W4380768830 hasAuthorship W4380768830A5020769521 @default.
• W4380768830 hasAuthorship W4380768830A5035478539 @default.
• W4380768830 hasAuthorship W4380768830A5062614206 @default.
• W4380768830 hasAuthorship W4380768830A5066100060 @default.
• W4380768830 hasAuthorship W4380768830A5067208399 @default.
• W4380768830 hasConcept C122246415 @default.
• W4380768830 hasConcept C126322002 @default.
• W4380768830 hasConcept C142724271 @default.
• W4380768830 hasConcept C143998085 @default.
• W4380768830 hasConcept C144301174 @default.
• W4380768830 hasConcept C167135981 @default.
• W4380768830 hasConcept C199343813 @default.
• W4380768830 hasConcept C204232928 @default.
• W4380768830 hasConcept C207103383 @default.
• W4380768830 hasConcept C2775876115 @default.
• W4380768830 hasConcept C2908647359 @default.
• W4380768830 hasConcept C38180746 @default.
• W4380768830 hasConcept C44249647 @default.
• W4380768830 hasConcept C50382708 @default.
• W4380768830 hasConcept C71924100 @default.
• W4380768830 hasConcept C72563966 @default.
• W4380768830 hasConcept C90924648 @default.
• W4380768830 hasConcept C99454951 @default.
• W4380768830 hasConceptScore W4380768830C122246415 @default.
• W4380768830 hasConceptScore W4380768830C126322002 @default.
• W4380768830 hasConceptScore W4380768830C142724271 @default.
• W4380768830 hasConceptScore W4380768830C143998085 @default.
• W4380768830 hasConceptScore W4380768830C144301174 @default.
• W4380768830 hasConceptScore W4380768830C167135981 @default.
• W4380768830 hasConceptScore W4380768830C199343813 @default.
• W4380768830 hasConceptScore W4380768830C204232928 @default.
• W4380768830 hasConceptScore W4380768830C207103383 @default.
• W4380768830 hasConceptScore W4380768830C2775876115 @default.
• W4380768830 hasConceptScore W4380768830C2908647359 @default.
• W4380768830 hasConceptScore W4380768830C38180746 @default.
• W4380768830 hasConceptScore W4380768830C44249647 @default.
• W4380768830 hasConceptScore W4380768830C50382708 @default.
• W4380768830 hasConceptScore W4380768830C71924100 @default.
• W4380768830 hasConceptScore W4380768830C72563966 @default.
• W4380768830 hasConceptScore W4380768830C90924648 @default.
• W4380768830 hasConceptScore W4380768830C99454951 @default.
• W4380768830 hasIssue "1" @default.
• W4380768830 hasLocation W43807688301 @default.
• W4380768830 hasOpenAccess W4380768830 @default.
• W4380768830 hasPrimaryLocation W43807688301 @default.
• W4380768830 hasRelatedWork W2361700749 @default.
• W4380768830 hasRelatedWork W2751913398 @default.
• W4380768830 hasRelatedWork W2761925198 @default.
• W4380768830 hasRelatedWork W2771629182 @default.
• W4380768830 hasRelatedWork W2789279481 @default.
• W4380768830 hasRelatedWork W2889343797 @default.
• W4380768830 hasRelatedWork W2906013683 @default.
• W4380768830 hasRelatedWork W2913104461 @default.
• W4380768830 hasRelatedWork W3093242228 @default.
• W4380768830 hasRelatedWork W4283321516 @default.
• W4380768830 hasVolume "136" @default.
• W4380768830 isParatext "false" @default.
• W4380768830 isRetracted "false" @default.
• W4380768830 workType "article" @default.